GSK Gets FDA Approval for New Severe Asthma Drug With a Dosing Advantage
Severe asthma is already treatable with a monthly injectable GSK drug, the blockbuster product Nucala. A new FDA approval gives the drugmaker the opportunity to reach patients with a ...